We are live on ! Find out more
AVNS icon

Avanos Medical
AVNS

349 hedge funds and large institutions have $1.29B invested in Avanos Medical in 2015 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 88 increasing their positions, 123 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

27% more capital invested

Capital invested by funds: $1.02B → $1.29B (+$271M)

1% less funds holding

Funds holding: 352 → 349 (-3)

2% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 52

16% less call options, than puts

Call options by funds: $4.83M | Put options by funds: $5.74M

28% less repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 123

Holders
349
Holders Change
-3
Holders Change %
-0.85%
% of All Funds
9.16%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
51
Increased
88
Reduced
123
Closed
52
Calls
$4.83M
Puts
$5.74M
Net Calls
-$915K
Net Calls Change
+$3.31M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$39.4M
2
CI
Cambiar Investors
Colorado
+$23.3M
3
SCM
Shapiro Capital Management
Georgia
+$17.1M
4
LCP
Lombardia Capital Partners
California
+$15.9M
5
Prudential Financial
Prudential Financial
New Jersey
+$13.2M

Top Sellers

1
RP
RR Partners
New York
-$17.9M
2
CIP
Champlain Investment Partners
Vermont
-$12.4M
3
MNA
Manning & Napier Advisors
New York
-$9.08M
4
HCM
Highbridge Capital Management
New York
-$7.94M
5
EAM
Edge Asset Management
Washington
-$6.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
WP
326
WealthPLAN Partners
Nebraska
$501 +$466 +15 New
CS
327
Credential Securities
$66 – – –
ED
328
Exane Derivatives
France
$33 – – –
RP
329
RR Partners
New York
– -$17.9M -629,401 Closed
HCM
330
Highbridge Capital Management
New York
– -$7.94M -255,341 Closed
EAM
331
Edge Asset Management
Washington
– -$6.5M -228,401 Closed
CAM
332
Cortina Asset Management
Wisconsin
– -$4.36M -153,347 Closed
PP
333
PDT Partners
New York
– -$2.55M -89,735 Closed
RA
334
Royce & Associates
New York
– -$2.4M -84,500 Closed
Axa
335
Axa
France
– -$2.29M -80,700 Closed
LD
336
Lipe & Dalton
New York
– -$1.76M -61,820 Closed
Point72 Asset Management
337
Point72 Asset Management
Connecticut
– -$1.43M -50,100 Closed
FFSOTS
338
Fiduciary Financial Services of The Southwest
Texas
– -$945K -33,217 Closed
CIC
339
Cornercap Investment Counsel
Georgia
– -$926K -32,545 Closed
Marshall Wace
340
Marshall Wace
United Kingdom
– -$731K -25,699 Closed
TI
341
Trexquant Investment
Connecticut
– -$728K -25,600 Closed
Massachusetts Financial Services
342
Massachusetts Financial Services
Massachusetts
– -$490K -17,227 Closed
Baird Financial Group
343
Baird Financial Group
Wisconsin
– -$399K -14,043 Closed
SO
344
STRS Ohio
Ohio
– -$361K -12,700 Closed
Allianz Asset Management
345
Allianz Asset Management
Germany
– -$338K -11,897 Closed
WPC
346
White Pine Capital
Minnesota
– -$310K -10,912 Closed
GIM
347
Grassi Investment Management
California
– -$297K -10,450 Closed
Nisa Investment Advisors
348
Nisa Investment Advisors
Missouri
– -$278K -9,722 Closed
CHJWM
349
Carlton Hofferkamp & Jenks Wealth Management
Texas
– -$265K -9,318 Closed
SCM
350
Stevens Capital Management
Pennsylvania
– -$265K -9,307 Closed
12 13
14
15 16

AVNS Hedge Fund Activity: Q4 2015 in Review

349 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2015, worth a combined $1.29B — up 27% from $1.02B a quarter earlier.

Sellers outnumbered buyers: 52 funds closed out of AVNS and 51 opened new positions — a net loss of 1 holder — while 123 trimmed existing stakes and 88 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $39.4M. The largest seller was RR Partners, exiting entirely with an estimated $17.9M sold.

  • 349 institutional investors held Avanos Medical (AVNS) as of Q4 2015, down from 352 in Q3 2015.
  • Funds reported $1.29B of Avanos Medical stock for Q4 2015, up 27% quarter-over-quarter.
  • 51 funds opened new Avanos Medical positions in Q4 2015 and 52 closed out, a net change of -1 holder.
  • The largest Avanos Medical buyer in Q4 2015 was T. Rowe Price Associates, an estimated $39.4M added.
  • The largest Avanos Medical seller in Q4 2015 was RR Partners, an estimated $17.9M sold.

Based on aggregated 13F filings for Q4 2015.